Evopoint Biosciences is an innovative biopharmaceutical company with exceptional R&D and commercialization capabilities. Since its inception, Evopoint has been committed to improving human health by providing cutting-edge pharmaceutical solutions to address significant unmet medical needs globally.
By leveraging diverse discovery platforms in targeted therapy, next-generation ADCs, and targeted protein degradation (TPD), Evopoint has developed a robust pipeline targeting oncology, infectious diseases and metabolic diseases. Currently, we have seven programs in active clinical development and 10+ programs at discovery and preclinical development stages.
On our way to be a fully integrated, global biopharma, Evopoint’s capabilities and programs have been well recognized by industry partners. Evopoint has established multiple discovery or development partnerships with leading global or domestic firms and obtained support from reputable investors.
At Evopoint, we make unremitting effort to protect and improve human health and quality of life. Evopoint -- inspiring innovation, improving lives.
Pipeline
Partnering
Investor
